+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Next-Generation Sequencing Sample Preparation Market by Product, Workflow, NGS Technology, Sample Type, Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • March 2025
  • Region: Global
  • 360iResearch™
  • ID: 5470903
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Next-Generation Sequencing Sample Preparation Market grew from USD 5.67 billion in 2024 to USD 6.34 billion in 2025. It is expected to continue growing at a CAGR of 12.16%, reaching USD 11.29 billion by 2030.

The field of next-generation sequencing (NGS) has revolutionized the way biological research and clinical diagnostics are conducted. With advancements that continuously reshape the scientific landscape, NGS sample preparation has emerged as a critical phase that directly influences data quality, reproducibility, and overall experimental success. As laboratories strive to meet growing demands for precision and scalability, the integration of state-of-the-art sample preparation techniques has become essential. This report provides an in-depth view that not only examines the evolution of methodologies in the NGS arena but also offers strategic insights into optimizing workflows and ensuring robust performance.

The transformational impact of innovations in sample processing and library management is evident through enhanced sensitivity, faster turnaround times, and the automation of previously labor-intensive procedures. Beneficiaries of these advancements range from academic researchers to clinical laboratories, each aiming to derive actionable biological insights through refined and sophisticated sequencing methodologies. In this comprehensive analysis, readers will gain a robust understanding of the diverse facets that underpin modern NGS sample preparation, setting the stage for addressing current challenges and capitalizing on emerging opportunities in the competitive sequencing landscape.

Transformative Shifts in the NGS Landscape

Recent years have witnessed a series of transformative shifts within the NGS landscape, driven primarily by technological advancements and evolving research requirements. The transition from conventional methods to high-throughput, automation-driven platforms has redefined sample processing efficiencies. These changes have fostered an environment where precision, speed, and cost-effectiveness are no longer mutually exclusive, enabling researchers to push the boundaries of genomic analysis.

Modern analytical systems now integrate sophisticated software and hardware innovations that allow for streamlined library preparation processes. Researchers have observed an increased emphasis on reducing manual intervention, thereby cutting down on errors and enhancing reproducibility. Furthermore, the shift toward integrated workflows - where extraction, amplification, quantification, and enrichment are collectively optimized - has proven pivotal in enhancing overall output quality. Industries are now adept at coping with the surge in data volumes while maintaining stringent quality controls, which underscores a broader trend towards democratization of NGS technologies.

These advancements have collectively contributed to a robust ecosystem where innovations in one segment often catalyze progress in others, ensuring that the technology not only meets current needs but is also adaptable for future challenges. This seamless interplay between various components of NGS sample preparation is a testament to the industry’s commitment to continual improvement and excellence.

Key Insights from Market Segmentation

An intricate analysis of the market segmentation in the NGS sample preparation domain reveals several dimensions that drive growth and innovation. Firstly, an examination based on product categorizes the market across the domains of instruments, reagents and consumables, and services. Each of these segments plays a significant role in enabling precision and efficiency, with instruments being the backbone of operational capacity, reagents and consumables ensuring the viability of biochemical reactions, and services providing critical technical support and consultation to enhance overall outcomes.

Delving deeper into the workflow segmentation illustrates the spectrum of processes including library preparation and amplification, library quantification and quality control, nucleic acid extraction, and target enrichment. These detailed phases underscore the meticulous nature of sample preparation and the necessity for specialized protocols that maintain the integrity of genetic material. Equally notable is how distinct sequencing technologies drive further segmentation; applications such as ChIP sequencing, exome sequencing, methylation sequencing, RNA sequencing, targeted sequencing, and whole genome sequencing each cater to highly specific research applications and clinical needs.

Additional segmentation based on sample type distinguishes between DNA and RNA, highlighting the operational differences in processing and analysis. This differentiation is further refined when considering application-centric segmentation where agricultural genomics, animal science and veterinary research, clinical diagnostics, clinical research and drug development, consumer genomics, and forensic studies each demand tailored approaches. Complementing these insights, the market is also segmented by end-user, covering academic and research institutions, hospitals and clinics, and pharmaceutical and biotechnology companies. Each segment not only reflects unique challenges but also encapsulates opportunities for innovation and value creation across the entire NGS ecosystem.

Based on Product, market is studied across Instruments, Reagents & Consumables, and Services.

Based on Workflow, market is studied across Library Preparation & Amplification, Library Quantification/QC, Nucleic Acid Extraction, and Target Enrichment.

Based on NGS Technology, market is studied across ChIP Sequencing (Chromatin Immunoprecipitation), Exome Sequencing, Methylation Sequencing, RNA Sequencing (RNA-Seq), Targeted Sequencing, and Whole Genome Sequencing (WGS).

Based on Sample Type, market is studied across DNA and RNA.

Based on Application, market is studied across Agricultural Genomics, Animal Science & Veterinary Research, Clinical Diagnostics, Clinical Research & Drug Development, Consumer Genomics, and Forensics.

Based on End User, market is studied across Academic & Research Institutions, Hospitals & Clinics, and Pharmaceutical & Biotechnology Companies.

Regional Dynamics and Market Opportunities

The geographic analysis of the NGS sample preparation market reveals diverse regional dynamics that collectively shape global trends. In the Americas, groundbreaking research institutions and a robust healthcare system have contributed to widespread adoption and continual refinement of sequencing protocols. This region remains a hotspot for technological advancement and an incubator for new methodologies.

Across Europe, the Middle East, and Africa, there is a growing convergence of academic research, public-private partnerships, and regulatory frameworks that are driving incremental yet impactful enhancements in sample preparation techniques. The region is marked by a unique interplay of legacy systems and modern innovations, creating an environment ripe for collaboration and technological integration.

In the Asia-Pacific, rapid industrial expansion coupled with increasing investments in scientific research has spurred significant growth in NGS applications. The unique market dynamics here are characterized by a combination of cost-effectiveness, scalability, and accessibility of state-of-the-art sequencing technologies. This region is rapidly evolving into a major player in the global NGS market, reflective of its dynamic research environment and its commitment to embracing the latest scientific advancements.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Insights into Leading Market Players

A comprehensive evaluation of market trends also reveals the strategic maneuvers of leading companies within the NGS sample preparation sector. Innovators such as Agilent Technologies, Inc. and Illumina, Inc. have consistently set benchmarks in terms of technology integration and operational excellence. Other key market contributors like Azenta Life Sciences, BGI Genomics Co., Ltd., and Biodiscovery, LLC have carved out significant niches by offering specialized products and services that address distinct laboratory needs.

Additional major players include Bio‐Rad Laboratories, Inc. and Charles River Laboratories International, Inc., both of which have significantly advanced sample processing technologies. Strategic investments and innovative product developments have been facilitated by industrial titans such as Danaher Corporation and F. Hoffmann-La Roche Ltd, who continue to nurture strong portfolios. Notable advancements are also driven by GenScript Biotech Corporation, Hamilton Bonaduz AG, and LGC Biosearch Technologies, which have demonstrated considerable expertise in niche segments.

Merck KGaA, Meridian Bioscience, Inc., and New England Biolabs, Inc. contribute through their robust research and development frameworks, while NimaGen B.V. and Omega Bio-tek, Inc. emphasize user-friendly solutions. Oxford Nanopore Technologies PLC and Pacific Biosciences of California, Inc. have recently gained prominence due to their disruptive sequencing platforms, and contributions from Parse Biosciences, PerkinElmer, Inc., and Promega Corporation have further diversified the competitive landscape. The combined efforts of QIAGEN N.V., Standard BioTools Inc., Takara Bio Inc., Thermo Fisher Scientific, Inc., Twist Bioscience Corporation, and Zymo Research Corporation illustrate a market characterized by constant evolution and robust competition, with each company contributing unique innovations that drive forward the entire sector.

The report delves into recent significant developments in the Next-Generation Sequencing Sample Preparation Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Azenta Life Sciences, BGI Genomics Co., Ltd., Biodiscovery, LLC, Bio‐Rad Laboratories, Inc., Charles River Laboratories International, Inc, Danaher Corporation, F. Hoffmann-La Roche Ltd, GenScript Biotech Corporation, Hamilton Bonaduz AG, Illumina, Inc., LGC Biosearch Technologies, Merck KGaA, Meridian Bioscience, Inc, New England Biolabs, Inc, NimaGen B.V., Omega Bio-tek, Inc., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., Parse Biosciences, PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Standard BioTools Inc., Takara Bio Inc., Thermo Fisher Scientific, Inc., Twist Bioscience Corporation, and Zymo Research Corporation.

Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to adopt proactive, data-driven strategies in order to excel within the competitive realm of NGS sample preparation. It is essential to continuously integrate emerging technologies such as automation and digital analytics to optimize workflow efficiency and quality control. Investment in cutting-edge equipment and advanced reagent formulations can provide a significant competitive advantage, ensuring higher throughput while minimizing errors and procedural bottlenecks.

Leaders should focus on forming strategic alliances and partnerships with both technology providers and key academic institutions. Such collaborations not only encourage innovation but also facilitate access to a broad spectrum of expertise, enabling rapid adaptation to new scientific challenges. Furthermore, a thorough understanding of regional market dynamics - whether in the Americas, Europe, Middle East, Africa, or Asia-Pacific - is critical to tailoring products and services that meet localized demands.

Finally, companies are advised to maintain robust customer feedback loops and invest in training programs that enhance technical proficiency. These efforts will help in rapidly assimilating feedback into practical improvements, thereby accelerating product enhancements and sustaining long-term growth in a dynamic market environment.

In summing up the current state of NGS sample preparation, it is evident that technological innovation and strategic segmentation are the cornerstone of progress in this field. With continuous advancements across multiple areas - from product diversification and workflow optimization to nuanced regional adaptations - the market is poised for further growth and increased operational efficiency.

The comprehensive analysis provided herein underscores the importance of a well-integrated approach that spans technological innovation, market segmentation, and regional dynamics. As competitors and collaborators alike continue to navigate this intricate landscape, the commitment to excellence in sample preparation has never been more pronounced. Looking ahead, stakeholders can expect accelerating developments in automation, precision, and data analytics to unlock further potential within the NGS value chain.

The future of sequencing sample preparation is marked by continuous improvement and strategic foresight. Organizations that successfully harness this potential will not only enhance their operational capabilities but also significantly contribute to the broader scientific and clinical communities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for precision medicine and personalized treatment plans enhancing adoption
5.1.1.2. Increasing utilization of next-generation sequencing in clinical diagnostics and research
5.1.2. Restraints
5.1.2.1. Lack of standardization in methodologies across different platforms
5.1.3. Opportunities
5.1.3.1. Integration of advanced microfluidic platforms and reagent innovations for cost effective NGS sample preparation
5.1.3.2. Convergence of AI and informatics to enhance data interpretation
5.1.4. Challenges
5.1.4.1. Maintaining sample integrity and minimizing cross-contamination
5.2. Market Segmentation Analysis
5.2.1. Product: Rising usage of instruments for high-throughput capabilities that enhance sample processing
5.2.2. Workflow: Utilization of nucleic acid extraction to improve yield and purity
5.2.3. NGS Technology: Growing demand for targeted sequencing for mutation profiling and personalized medicine
5.2.4. Sample Type: Increasing usage of DNA samples due to its high stability
5.2.5. Application: Preference of usage in consumer genomics for comprehensive data interpretation
5.2.6. End User: Adaption in pharmaceutical & biotechnology companies for accelerating clinical trials
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Next-Generation Sequencing Sample Preparation Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Reagents & Consumables
6.4. Services
7. Next-Generation Sequencing Sample Preparation Market, by Workflow
7.1. Introduction
7.2. Library Preparation & Amplification
7.3. Library Quantification/QC
7.4. Nucleic Acid Extraction
7.5. Target Enrichment
8. Next-Generation Sequencing Sample Preparation Market, by NGS Technology
8.1. Introduction
8.2. ChIP Sequencing (Chromatin Immunoprecipitation)
8.3. Exome Sequencing
8.4. Methylation Sequencing
8.5. RNA Sequencing (RNA-Seq)
8.6. Targeted Sequencing
8.7. Whole Genome Sequencing (WGS)
9. Next-Generation Sequencing Sample Preparation Market, by Sample Type
9.1. Introduction
9.2. DNA
9.3. RNA
10. Next-Generation Sequencing Sample Preparation Market, by Application
10.1. Introduction
10.2. Agricultural Genomics
10.3. Animal Science & Veterinary Research
10.4. Clinical Diagnostics
10.5. Clinical Research & Drug Development
10.6. Consumer Genomics
10.7. Forensics
11. Next-Generation Sequencing Sample Preparation Market, by End User
11.1. Introduction
11.2. Academic & Research Institutions
11.3. Hospitals & Clinics
11.4. Pharmaceutical & Biotechnology Companies
12. Americas Next-Generation Sequencing Sample Preparation Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Next-Generation Sequencing Sample Preparation Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Next-Generation Sequencing Sample Preparation Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Scenario Analysis
15.3.1. New England Biolabs demonstrates advanced next-generation sequencing sample preparation innovations with streamlined workflows
15.3.2. Roche’s innovative SBX technology transforms next-generation sequencing sample preparation by integrating advanced synthetic molecules
15.3.3. Foresee Genomics secures USD 1.3 million SAFE financing to launch next-generation sequencing solutions and democratize precision medicine for small and medium-sized labs
15.3.4. Twist Bioscience introduces the flexprep ultra-high throughput library preparation kit that eliminates upfront quantitation
15.3.5. Illumina launches MiSeq i100 series to streamline next-generation sequencing sample preparation with room-temperature reagents
15.3.6. Illumina launches Global Capability Center in Bengaluru to expand next-generation sequencing capabilities and invest in local talent
15.3.7. Illumina integrates Fluent BioSciences’ innovative PIPseq V technology to drive scalable, cost-effective single-cell analysis
15.3.8. Jumpcode Genomics and Takara Bio USA develop a global CRISPR partnership to transform NGS sample preparation
15.3.9. QIAGEN launches advanced library preparation kit that streamlines multiomic integration to propel precision medicine advances
15.3.10. SPT Labtech and Watchmaker Genomics drive transformation in next-generation sequencing by automating library preparation to reduce processing times
15.3.11. NewBiologix launches an integrated next-generation sequencing and optical mapping platform that streamlines sample preparation
15.3.12. SeqWell’s ExpressPlex HT library preparation kit streamlines next-generation sequencing by integrating rapid barcoding and amplification to reduce consumable waste
15.3.13. Standard BioTools and Next Gen Diagnostics partner for advanced automation in pathogen whole genome sequencing sample preparation
15.3.14. Volta Labs partners with Qiagen to accelerate next-generation sequencing sample preparation through electrowetting-based automation for enhanced efficiency
15.3.15. Complete Genomics and seqWell partner to develop ultra-high-throughput NGS library preparation workflows that lower costs and accelerate advancements in synthetic biology and genomic screening
15.4. Strategy Analysis & Recommendation
15.4.1. Agilent Technologies, Inc.
15.4.2. F. Hoffmann-La Roche Ltd.
15.4.3. QIAGEN N.V.
15.4.4. Illumina, Inc.
List of Figures
FIGURE 1. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET MULTI-CURRENCY
FIGURE 2. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET MULTI-LANGUAGE
FIGURE 3. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET RESEARCH PROCESS
FIGURE 4. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2024 VS 2030
FIGURE 5. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 6. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 9. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2024 VS 2030 (%)
FIGURE 11. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 13. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 15. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 17. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 18. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 19. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 20. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 21. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 23. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 24. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 25. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 28. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 29. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET DYNAMICS
TABLE 7. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY LIBRARY PREPARATION & AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY LIBRARY QUANTIFICATION/QC, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NUCLEIC ACID EXTRACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY TARGET ENRICHMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CHIP SEQUENCING (CHROMATIN IMMUNOPRECIPITATION), BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY METHYLATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY RNA SEQUENCING (RNA-SEQ), BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY TARGETED SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WHOLE GENOME SEQUENCING (WGS), BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY DNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY RNA, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY AGRICULTURAL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ANIMAL SCIENCE & VETERINARY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CLINICAL RESEARCH & DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY CONSUMER GENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY FORENSICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 58. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 60. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. CANADA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 64. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 66. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. MEXICO NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 90. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 92. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. CHINA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 96. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 98. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. INDIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. INDONESIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 104. INDONESIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 108. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 110. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. JAPAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. MALAYSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 116. MALAYSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. MALAYSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. PHILIPPINES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 122. PHILIPPINES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. PHILIPPINES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. SINGAPORE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 128. SINGAPORE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SINGAPORE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 134. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. SOUTH KOREA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. TAIWAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 140. TAIWAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. TAIWAN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. THAILAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. THAILAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 144. THAILAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. THAILAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 146. THAILAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. THAILAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. VIETNAM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 152. VIETNAM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. VIETNAM NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 161. DENMARK NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. DENMARK NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 163. DENMARK NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. DENMARK NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 165. DENMARK NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. DENMARK NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. EGYPT NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. EGYPT NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 169. EGYPT NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. EGYPT NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 171. EGYPT NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. EGYPT NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. FINLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. FINLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 175. FINLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. FINLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 177. FINLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. FINLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 181. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 183. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 184. FRANCE NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 187. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 189. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. GERMANY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 193. ISRAEL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. ISRAEL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 195. ISRAEL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. ISRAEL NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 199. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 201. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. ITALY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. NORWAY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. NORWAY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 217. NORWAY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. NORWAY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 219. NORWAY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. NORWAY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. POLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. POLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 223. POLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. POLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 225. POLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. POLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. QATAR NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. QATAR NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 229. QATAR NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. QATAR NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 231. QATAR NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 232. QATAR NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 253. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 255. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 256. SPAIN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 261. SWEDEN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. SWEDEN NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. TURKEY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 270. TURKEY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
TABLE 271. TURKEY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY NGS TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. TURKEY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 273. TURKEY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. TURKEY NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES NEXT-GENERATION SEQUENCING SAMPLE PREPARATI

Companies Mentioned

  • Agilent Technologies, Inc.
  • Azenta Life Sciences
  • BGI Genomics Co., Ltd.
  • Biodiscovery, LLC
  • Bio‐Rad Laboratories, Inc.
  • Charles River Laboratories International, Inc
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • GenScript Biotech Corporation
  • Hamilton Bonaduz AG
  • Illumina, Inc.
  • LGC Biosearch Technologies
  • Merck KGaA
  • Meridian Bioscience, Inc
  • New England Biolabs, Inc
  • NimaGen B.V.
  • Omega Bio-tek, Inc.
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California, Inc.
  • Parse Biosciences
  • PerkinElmer, Inc.
  • Promega Corporation
  • QIAGEN N.V.
  • Standard BioTools Inc.
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • Twist Bioscience Corporation
  • Zymo Research Corporation

Methodology

Loading
LOADING...

Table Information